🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a double-blind, randomised, placebo-controlled, parallel-group, mu...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820585
Treatments Being Tested
Single centre, two-way crossover, randomised, open-label study in 20 health...
Status
Completed
Location
BIAL - Portela & Cª, S.A.
Start Date
2005-03
Trial ID
NCT02281448
Treatments Being Tested
The purpose of this study is to investigate the safety and tolerability of ...
Status
Completed
Location
Guy's Drug Research Unit
Start Date
2001-02
Trial ID
NCT02171234
Open-label study in two parallel groups of 20 healthy subjects each. Group ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT02284854
Treatments Being Tested
This is an 18-week, double-blind, multicenter study with gradual conversion...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2010-06
Trial ID
NCT01091662
Treatments Being Tested
The purpose of this study is to determine whether the test product, eslicar...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-03
Trial ID
NCT03116321
Treatments Being Tested
This was a phase III 4-part study in multiple centres. Part I was a 26-week...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957684
Treatments Being Tested
This is an open Label study to investigate the safety and efficacy of eslic...
Status
Completed
Location
Universitätsklinik für Neurologie; Arbeitsgruppe Epileptologie
Start Date
2010-04
Trial ID
NCT01422720
Treatments Being Tested
Single centre, randomised, open-label, two-way crossover study to investiga...
Status
Completed
Location
Human Pharmacology Unit
Start Date
2007-10
Trial ID
NCT02777671
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics of Eslica...
Status
Completed
Location
Clinica de Neurologie Pediatrica, Spitalul "Alexandru Obregia"
Start Date
2005-06
Trial ID
NCT02170064
Treatments Being Tested